NASDAQ$EKSO
Ekso Bionics Holdings Inc · Q1 2024 earnings
Q1 2024 earnings · · Investor relations
Briefing
Ekso Bionics reported first quarter 2024 financial results, showing a decrease in revenue but an increase in gross margin.
Ekso Bionics reported a revenue of $3.8 million for Q1 2024, compared to $4.1 million in the same period last year. The company's gross margin increased to 52%, and the net loss decreased to $3.4 million, or $0.20 per share.
- Revenue was $3.8 million, down from $4.1 million in the same quarter of the previous year.
- Gross profit reached $2.0 million, with a gross margin of approximately 52%.
- Net loss applicable to common stockholders was $3.4 million, or $0.20 per share.
- Cash and restricted cash stood at $8.8 million as of March 31, 2024.
Headline financials
Revenue & EPS history
Ekso Bionics · Revenue · Quarterly
$3.76M
Forward guidance
Ekso Bionics is focused on developing the market for Indego Personal and strengthening relationships with network operators for Enterprise devices.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 19 quarterly earnings reports · overlaid with Q1 2024
-4.1%
Avg return
Earnings day
-1.6%
Avg return
5 days after
-4.0%
Avg return
30 days after
23%
11 / 47 earnings
Positive
+31.9%
Q2 2018
Best reaction
-27.4%
Q2 2025
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q4 2026 | — | — | — | |
| Q3 2025 | -2.2% | +9.6% | -9.1% | |
| Q2 2025 | -27.4% | -23.0% | -14.1% | |
| Q1 2025 | -9.1% | -10.4% | -39.7% | |
| Q4 2024 | -1.2% | -19.9% | -13.2% | |
| Q3 2024 | -7.7% | -14.7% | -36.2% | |
| Q2 2024 | -9.1% | -9.2% | +25.0% | |
| Q1 2024 | -0.8% | +4.8% | -5.2% | |
| Q4 2023 | -20.6% | -22.6% | -27.6% | |
| Q3 2023 | -0.2% | +36.2% | +100.0% | |
| Q2 2023 | -5.6% | -11.2% | -24.5% | |
| Q1 2023 | +6.4% | +3.6% | +0.0% | |
| Q4 2022 | -4.5% | +7.1% | -6.5% | |
| Q3 2022 | -9.8% | -6.7% | -25.1% | |
| Q2 2022 | +2.9% | +7.0% | +37.4% | |
| Q1 2022 | -7.3% | -4.9% | -24.9% | |
| Q4 2021 | +6.6% | +7.9% | +26.6% | |
| Q3 2021 | +8.1% | +7.1% | -18.9% | |
| Q2 2021 | -0.2% | +4.3% | -4.3% | |
| Q1 2021 | +2.1% | -1.8% | +2.2% | |
| Q4 2020 | -10.2% | -8.8% | -21.9% | |
| Q3 2020 | -1.7% | +0.5% | +38.2% | |
| Q2 2020 | -10.9% | -13.4% | -30.2% | |
| Q1 2020 | -4.5% | -8.1% | -3.3% | |
| Q4 2019 | -19.5% | -13.7% | -32.9% | |
| Q3 2019 | -7.1% | -12.9% | -18.0% | |
| Q2 2019 | -21.2% | -23.0% | -45.1% | |
| Q1 2019 | -3.2% | -4.1% | -39.5% | |
| Q4 2018 | -0.9% | +2.1% | +7.7% | |
| Q3 2018 | +1.4% | +1.9% | -14.5% | |
| Q2 2018 | +31.9% | +44.5% | +34.1% | |
| Q1 2018 | -6.8% | -9.7% | +3.4% | |
| Q4 2017 | -13.7% | -13.1% | -10.9% | |
| Q3 2017 | -6.3% | +80.4% | +145.5% | |
| Q2 2017 | -1.6% | -1.3% | -21.4% | |
| Q1 2017 | -19.5% | -36.3% | -53.5% | |
| Q4 2016 | +0.6% | -6.1% | +0.0% | |
| Q3 2016 | +4.2% | +0.2% | +7.8% | |
| Q2 2016 | -3.1% | -2.8% | -39.5% | |
| Q1 2016 | -3.1% | — | — | |
| Q4 2015 | -1.2% | — | — | |
| Q3 2015 | -2.6% | — | — | |
| Q2 2015 | -3.6% | — | — | |
| Q1 2015 | -9.6% | — | — | |
| Q4 2014 | +1.2% | — | — | |
| Q3 2014 | +10.4% | — | — | |
| Q2 2014 | -10.4% | — | — | |
| Q1 2014 | -1.8% | — | — | |
| Q4 2013 | — | — | — | |
| Q3 2013 | — | — | — | |
| Q2 2013 | — | — | — | |
| Q1 2013 | — | — | — | |
| Q4 2012 | — | — | — | |
| Q3 2012 | — | — | — | |
| Q2 2012 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro